Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
Sun C, Shen L, Zhang Z, Xie X.
Genes (Basel). 2020 Jul 23;11(8):837. doi: 10.3390/genes11080837.
Duchenne muscular dystrophy.
Yiu EM, Kornberg AJ.
J Paediatr Child Health. 2015 Aug;51(8):759-64. doi: 10.1111/jpc.12868. Epub 2015 Mar 9.
CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy.
Happi Mbakam C, Lamothe G, Tremblay G, Tremblay JP.
Neurotherapeutics. 2022 Apr;19(3):931-941. doi: 10.1007/s13311-022-01197-9. Epub 2022 Feb 14.
[Update on Duchenne muscular dystrophy].
Leiva-Cepas F, Montaño Martínez A, López-López I.
Semergen. 2021 Oct;47(7):472-481. doi: 10.1016/j.semerg.2021.06.008. Epub 2021 Aug 18.
Duchenne muscular dystrophy: promising early-stage clinical trials to watch.
Tang A, Yokota T.
Expert Opin Investig Drugs. 2024 Mar;33(3):201-217. doi: 10.1080/13543784.2024.2313105. Epub 2024 Feb 6.
Evolving Therapeutic Options for the Treatment of Duchenne Muscular Dystrophy.
D'Ambrosio ES, Mendell JR.
Neurotherapeutics. 2023 Oct;20(6):1669-1681. doi: 10.1007/s13311-023-01423-y. Epub 2023 Sep 6.
Duchenne muscular dystrophy: an overview to the cardiologist.
de Souza F, Bittar Braune C, Dos Santos Nucera APC.
Expert Rev Cardiovasc Ther. 2020 Dec;18(12):867-872. doi: 10.1080/14779072.2020.1828065. Epub 2020 Oct 12.
Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committee.
Esteso P, Auerbach SR, Bansal N, Harris R, Soslow JH, Birnbaum BF, Conway J, Cripe LH, Nandi D, Hayes E, Gambetta KE, Hall EK, Hsu DT, Kaufman BD, Rosenthal D, Kirmani S, Ploutz MS, Lal AK, Peng DM, Villa CR, Shugh S, Wittlieb-Weber CA, Shih R.
Cardiol Young. 2025 Apr;35(4):770-775. doi: 10.1017/S1047951125000587. Epub 2025 Feb 27.
Duchenne muscular dystrophy.
Yiu EM, Kornberg AJ.
Neurol India. 2008 Jul-Sep;56(3):236-47. doi: 10.4103/0028-3886.43441.
Duchenne muscular dystrophy.
Sussman M.
J Am Acad Orthop Surg. 2002 Mar-Apr;10(2):138-51. doi: 10.5435/00124635-200203000-00009.
